NEW YORK – The US Food and Drug Administration said Friday evening that it has reissued an Emergency Use Authorization for Laboratory Corporation of America's COVID-19 RT-PCR Test for testing the broad population, even if they are asymptomatic, and for pooled testing for SARS-CoV-2, the virus that causes COVID-19.
The FDA reissued the EUA for the new uses after LabCorp provided data showing the test could detect SARS-CoV-2 in a general asymptomatic population, the agency said. LabCorp originally received EUA for the test in March.